Pregled bibliografske jedinice broj: 1171384
Phototherapy (UVB) and Photochemotherapy (PUVA) for Psoriasis
Phototherapy (UVB) and Photochemotherapy (PUVA) for Psoriasis // Acta clinica Croatica, 41 (2002), 1; 103-112 (međunarodna recenzija, pregledni rad, stručni)
CROSBI ID: 1171384 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Phototherapy (UVB) and Photochemotherapy (PUVA) for
Psoriasis
Autori
Kostović Krešimir ; Šitum Mirna ; Nola Ivana
Izvornik
Acta clinica Croatica (0353-9466) 41
(2002), 1;
103-112
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, stručni
Ključne riječi
psorijaza ; liječenje ; ultraljubičasta terapija ; metode ; PUVA terapija ; ultraljubičasta terapija
(psoriasis ; therapy ; ultraviolet therapy ; methods ; PUVA therapy methods ; Ultraviolet therapy ; adverse effects)
Sažetak
The review covers the current practice of phototherapy with ultraviolet (UV) radiation without sensitizers and of psoralen photochemotherapy (PUVA) in the treatment of psoriasis. There are several types of UVB radiation in clinical use: traditional or broad band UVB (280 ∑ 320 nm) ; selective UVB (305 ∑ 325 nm) ; and narrow band UVB (311 nm). Forms of PUVA therapy are: systemic photochemotherapy (PUVA therapy with oral administration of psoralen) ; PUVA bath therapy ; and PUVA therapy with topical psoralen application. PUVA therapy is more effective than UVB therapy in clearing psoriasis in most patients, but since UVB is easier to administer and does not involve an oral photosensitizing medication, it is often selected before PUVA. UVB and PUVA have been administered alone or in combination with topical corticosteroids, salicylic acid, anthralin, calcipotriol and tazarotene, and with systemic therapies such as retinoids. The most important potential long-term side effects of UVB and PUVA are accelerated skin aging and an increased risk of cutaneous cancer.
Izvorni jezik
Engleski
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus